158 related articles for article (PubMed ID: 37499899)
1. Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency.
Di Giorgio A; Sciveres M; Fuoti M; Sonzogni A; Mandato C; D'Antiga L
Clin Res Hepatol Gastroenterol; 2023 Oct; 47(8):102185. PubMed ID: 37499899
[TBL] [Abstract][Full Text] [Related]
2. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
Thompson RJ; Arnell H; Artan R; Baumann U; Calvo PL; Czubkowski P; Dalgic B; D'Antiga L; Durmaz Ö; Fischler B; Gonzalès E; Grammatikopoulos T; Gupte G; Hardikar W; Houwen RHJ; Kamath BM; Karpen SJ; Kjems L; Lacaille F; Lachaux A; Lainka E; Mack CL; Mattsson JP; McKiernan P; Özen H; Rajwal SR; Roquelaure B; Shagrani M; Shteyer E; Soufi N; Sturm E; Tessier ME; Verkade HJ; Horn P
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):830-842. PubMed ID: 35780807
[TBL] [Abstract][Full Text] [Related]
3. Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis.
Slavetinsky C; Sturm E
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601135
[TBL] [Abstract][Full Text] [Related]
4. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis.
Pepe A; Colucci A; Carucci M; Nazzaro L; Bucci C; Ranucci G; Di Giorgio A; Vajro P; Mandato C
Front Pediatr; 2023; 11():1061535. PubMed ID: 36865697
[TBL] [Abstract][Full Text] [Related]
6. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.
Kamath BM; Stein P; Houwen RHJ; Verkade HJ
Liver Int; 2020 Aug; 40(8):1812-1822. PubMed ID: 32492754
[TBL] [Abstract][Full Text] [Related]
7. Odevixibat: First Approval.
Deeks ED
Drugs; 2021 Oct; 81(15):1781-1786. PubMed ID: 34499340
[TBL] [Abstract][Full Text] [Related]
8. Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis.
Bedoyan SM; Lovell OT; Horslen SP; Squires JE
Expert Opin Pharmacother; 2022 Nov; 23(16):1771-1779. PubMed ID: 36278881
[TBL] [Abstract][Full Text] [Related]
9. Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis-Case Compilation and Review of the Literature.
Hüpper MN; Pichler J; Huber WD; Heilos A; Schaup R; Metzelder M; Langer S
Children (Basel); 2023 May; 10(6):. PubMed ID: 37371180
[TBL] [Abstract][Full Text] [Related]
10. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.
Thompson RJ; Artan R; Baumann U; Calvo PL; Czubkowski P; Dalgic B; D'Antiga L; Di Giorgio A; Durmaz Ö; Gonzalès E; Grammatikopoulos T; Gupte G; Hardikar W; Houwen RHJ; Kamath BM; Karpen SJ; Lacaille F; Lachaux A; Lainka E; Loomes KM; Mack CL; Mattsson JP; McKiernan P; Ni Q; Özen H; Rajwal SR; Roquelaure B; Shteyer E; Sokal E; Sokol RJ; Soufi N; Sturm E; Tessier ME; van der Woerd WL; Verkade HJ; Vittorio JM; Wallefors T; Warholic N; Yu Q; Horn P; Kjems L
JHEP Rep; 2023 Aug; 5(8):100782. PubMed ID: 37456676
[TBL] [Abstract][Full Text] [Related]
11. Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease.
Ge T; Zhang X; Xiao Y; Wang Y; Zhang T
BMC Med Genet; 2019 Jan; 20(1):18. PubMed ID: 30658709
[TBL] [Abstract][Full Text] [Related]
12. Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
Loomes KM; Squires RH; Kelly D; Rajwal S; Soufi N; Lachaux A; Jankowska I; Mack C; Setchell KDR; Karthikeyan P; Kennedy C; Dorenbaum A; Desai NK; Garner W; Jaecklin T; Vig P; Miethke A; Thompson RJ
Hepatol Commun; 2022 Sep; 6(9):2379-2390. PubMed ID: 35507739
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency.
Li CZ; Ogawa H; Ng SS; Chen X; Kishimoto E; Sakabe K; Fukami A; Hu YC; Mayhew CN; Hellmann J; Miethke A; Tasnova NL; Blackford SJI; Tang ZM; Syanda AM; Ma L; Xiao F; Sambrotta M; Tavabie O; Soares F; Baker O; Danovi D; Hayashi H; Thompson RJ; Rashid ST; Asai A
JHEP Rep; 2022 Apr; 4(4):100446. PubMed ID: 35284810
[TBL] [Abstract][Full Text] [Related]
14. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Xu J; Kausalya PJ; Van Hul N; Caldez MJ; Xu S; Ong AGM; Woo WL; Mohamed Ali S; Kaldis P; Hunziker W
Gastroenterology; 2021 May; 160(6):2103-2118. PubMed ID: 33465371
[TBL] [Abstract][Full Text] [Related]
15. Odevixibat: an investigational inhibitor of the ileal bile acid transporter (IBAT) for the treatment of biliary atresia.
Laue T; Baumann U
Expert Opin Investig Drugs; 2022 Nov; 31(11):1143-1150. PubMed ID: 36440482
[TBL] [Abstract][Full Text] [Related]
16. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
17. Odevixibat: A Review of a Bioactive Compound for the Treatment of Pruritus Approved by the FDA.
Porwal M; Kumar A; Rastogi V; Maheshwari KK; Verma A
Curr Drug Res Rev; 2023 Mar; ():. PubMed ID: 36892028
[TBL] [Abstract][Full Text] [Related]
18. Progressive Familial Intrahepatic Cholestasis.
Bull LN; Thompson RJ
Clin Liver Dis; 2018 Nov; 22(4):657-669. PubMed ID: 30266155
[TBL] [Abstract][Full Text] [Related]
19. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report.
Wei CS; Becher N; Friis JB; Ott P; Vogel I; Grønbæk H
World J Gastroenterol; 2020 Feb; 26(5):550-561. PubMed ID: 32089630
[TBL] [Abstract][Full Text] [Related]
20. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
Gwaltney C; Ivanescu C; Karlsson L; Warholic N; Kjems L; Horn P
Adv Ther; 2022 Nov; 39(11):5105-5125. PubMed ID: 36066745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
